Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 79 | PDF Downloads 57
PDF

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 57 | PDF Downloads 35
PDF

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 73 | PDF Downloads 33
PDF

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 296 | PDF Downloads 84
PDF

ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Gideon Koren
Abstract 139 | PDF Downloads 31
PDF

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 230 | PDF Downloads 48
PDF

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 69 | PDF Downloads 64
PDF

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 281 | PDF Downloads 89
PDF

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 516 | PDF Downloads 362
PDF

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 68 | PDF Downloads 33
PDF

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 50 | PDF Downloads 33
PDF

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 53 | PDF Downloads 25
PDF

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 191 | PDF Downloads 39
PDF

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 63 | PDF Downloads 38
PDF

ESTABLISHING A NEW BENCHMARK FOR DRUG EVALUATION DURING PREGNANCY

Gideon Koren
Abstract 334 | PDF Downloads 28
PDF